Abstract
The faithful repair of DNA damage, especially chromosomal double-strand breaks (DSBs), is crucial for genomic integrity. We have previously shown that securin interacts with the Ku70/80 heterodimer of the DSB non-homologous DNA end-joining (NHEJ) repair machinery. Here we demonstrate that securin deficiency compromises cell survival and proliferation, but only after genotoxic stress. Securin−/− cells show a significant increase in gross chromosomal rearrangements and chromatid breaks after DNA damage, and also reveal an altered pattern of end resection in an NHEJ assay in comparison with securin+/+ cells. These data suggest that securin has a key role in the maintenance of genomic stability after DNA damage, thereby providing a previously unknown mechanism for regulating tumour progression.
Similar content being viewed by others
Main
The gene encoding securin/PTTG1, an inhibitor of separase activity, is implicated in functional mechanisms related to cell-cycle control and tumorigenesis.1, 2 Separase function is required for sister-chromatid separation during cell division. Degradation of securin at the metaphase–anaphase transition is essential for proper chromosome segregation. A role for securin in cancer pathogenesis is supported by the observation of increased expression of securin in different tumours3, 4, 5 and in samples under a putative metastasis programme.6 Securin overexpression, in breast cancers, also correlates with lymph node infiltration and with a higher degree of tumour recurrence. We have shown that securin interacts with p53, represses its transcriptional activity and reduces its ability to induce cell death in vivo, giving insights into how some tumour cells harbouring functional p53 are resistant to chemotherapy.7 However, the majority of tumour cells are deficient in p53 function and thus the elucidation of other mechanisms, which affect the ability of cells to proliferate after exposure to genotoxic chemotherapy in this setting, is crucial to the problem of drug resistance.
DNA repair abnormalities and genetic instability have long been considered key to the process of tumorigenesis, as evidenced by the presence of frequent chromosomal anomalies such as deletion, inversion or translocation in tumours. The DNA double-strand break (DSB) is a severe form of template damage that, if not properly repaired, can result in chromosomal rearrangements and tumour development. Mammalian cells generally repair DSBs by either the homologous recombination (HR) or the non-homologous DNA end-joining (NHEJ) pathways. HR is primarily an error-free system participating in the maintenance of genome stability, while NHEJ is error prone and thus a likely candidate pathway leading to genome rearrangement.8, 9 NHEJ repair requires the DNA-dependent protein kinase complex (DNA-PK). Mutations in genes of DNA-PK complex components lead to DSB repair deficiency, chromosomal instability and extreme sensitivity to DNA damage.10, 11 We have also shown that securin interacts in vivo and in vitro with the Ku heterodimer, the regulatory subunit of the DNA repair protein DNA-PK. The fact that the association between securin and the Ku heterodimer is disrupted and prevented by DSBs suggests that securin might play a role in the process or regulation of NHEJ12 and affect the response of cells to the genotoxic stress induced by conventional cancer therapies.
To address these points, we began by investigating the role of securin in cellular responses to genotoxic stresses, in particular that of proliferation and then analysed the effect of securin loss on the NHEJ repair pathway. We show that securin-deficient cells have a significant decrease in proliferative potential after exposure to DNA-damaging agents, such as adriamycin (Adr), methyl methanesulphonate (MMS) or ionizing radiation (IR), than are wild-type cells. To define further the nature of the DNA damage response defect in securin-deficient cell lines, we analysed the repair of DSBs in NHEJ substrates in vitro and in vivo and showed a qualitative but not quantitative defect in the re-sealing of DSBs. Using Adr treatment as a model of DSB induction, we conclude that securin is important for chromosomal stability after genotoxin-mediated DNA damage, with possible therapeutic implications considering existing data on its deregulation in cancer.
Results
Gross chromosomal aberrations are seen in securin-null cells after exposure to genotoxic stress
sec−/− HCT116 cells have been reported to show defects in chromosomal segregation leading to aneuploidy.13 However this phenotype has been since noted to revert after a short period in culture.14 We confirm by karyotypic analysis of metaphase spreads at different points in culture (8, 12 and 20 passage) that the sec−/− cells used in our experiments have a stable chromosomal set (Figure 1a). We have previously shown that securin loss sensitizes cells to the chemotherapeutic agent 5-FU and the protein modulates p53 activity in vivo suggesting a role in DNA damage response pathways.7 To characterize further these cellular responses to genotoxic stress, we looked at chromosomal integrity after DNA damage using the metaphase spread technique. Gross chromosomal rearrangements (GCRs) are typically formed when interactions between multiple broken DNA ends, which bear little or no homology, culminate in indiscriminate ligation of one to the other.15 A representative metaphase of sec−/− HCT116 cells after exposure to the topoisomerase II (topo II) inhibitor Adr revealed random non-reciprocal translocations and fusions involving different chromosomes with a loss of normal morphology (mean±S.E.M.: 1.32±0.25, n=25) (Figure 1b). Such lesions were not induced at the same level (mean±S.E.M.: 0.45±0.27, n=20) in control cells treated with the same amount of Adr (Figure 1c). This Adr effect on securin-deficient cells was significantly different as compared to respective control cells values (P=0.0243, two-tailed unpaired t-test). At the same time, no difference was observed between number of GCRs in sec−/− HCT116 and sec+/+ HCT116 without treatment (P=0.5602, two-tailed unpaired t-test).
Adr treatment differentially affects the cell cycle of sec−/− HCT116 cells
A predominant function of the DNA damage response pathway is to coordinate checkpoints that prevent progression of cells through the cell cycle in the presence of damaged DNA. HCT116 cells are checkpoint proficient and display flow cytometric profiles characteristic of the expected G1/S and G2/M arrests after exposure to Adr for 72 h. Cells showed an increased sub-G1 peak (apoptotic cells) and S phase, which suggests the existence of a viable population that has been able to repair the damaged DNA and continue along the cycle, and a second population that died after DNA damage (Figure 2a). Percentages of different cell populations treated with 0.2 μg/ml Adr in each cell-cycle phase are shown in Figure 2b. sec−/− HCT116 cells initially showed a similar response to drug treatment but began to differ by 72 h post-insult. Securin-deficient cells maintained the G1 and G2/M arrest, with a persistent suppression of DNA replication unlike their isogenic counterparts (Figure 2a and b). The decrease in number of cells re-entering S phase and mitosis after drug exposure was confirmed by bromodeoxyuridine (BrdU) incorporation and scoring of the mitotic index (Figure 2c and d). Low concentration of Adr notably arrested DNA synthesis in sec−/− HCT116 cells compared to control cells that could maintain BrdU incorporation even at 0.2 μg/ml Adr, confirming that securin null cells are not re-entering the cell cycle. Similarly, exposure of securin-deficient cells to Adr resulted in statistically significant (P<0.0001, two-tailed unpaired t-test) decrease in the percentage of mitotic cells compared to the untreated population (mean±S.E.M.: 1.6±0.21, n=1000 versus mean±S.E.M.: 3.7±0.28, n=1000) corroborating a persistent block at G2 in sec−/− HCT116 cells. Moreover, following HCT116 cells after DNA damage using time lapse, cells do not show any mitotic feature previous to apoptotic cell death (Supplementary Figure 2). In contrast to what is observed in securin-deficient cells, wild-type cells showed chromatin condensation, a feature of apoptotic cells, that was prevented by the addition of z-VAD, a potent apoptosis inhibitor (Supplementary Figure 1). Consistently, under the same conditions, both PARP and caspase 3 cleavages were specifically observed in sec+/+ HCT116 cells but not in sec−/− HCT116 cells, confirming that the sub-G1 population was indeed apoptotic (Figure 2e and f). These results also indicate that apoptosis is not the cause for the decrease of sec−/− HCT116 cells in S phase after DNA damage.
Securin-deficiency affects the survival of cells exposed only to certain DNA-damaging agents
The altered cell-cycle profile after DNA damage in sec−/− HCT116 cells could have effects on proliferative potential. To test this hypothesis we performed colony formation assays after exposure to different genotoxic agents. The sec−/− HCT116 cells exhibited enhanced sensitivity to Adr treatment in a dose-dependent manner when compared with wild-type HCT116 cells (Figure 3a). Similar findings were obtained after treatment with two other known genotoxins: IR and the DNA-alkylating agent MMS, highlighting the importance of the presence of securin in cell growth after DNA damage. However, when cells were grown in the presence of camptothecin (CPT), no differences between sec−/− and sec+/+ cells were observed. CPT binds specifically to topo I, inducing its degradation via the proteasome. This leads to single-strand nicks on DNA that interfere with replication fork progression, inducing DSBs. The induction of DSB after these insults was confirmed by immunostaining against γ-H2AX, a known early marker for DSB response activation. Treatment with Adr, MMS and IR induced γ-H2AX foci formation in over 95% of the cells visualized (Figure 3b). CPT treatment caused less than 15% of cells to be marked as positive for DSBs. These results are in agreement with the dependence of CTP on the replication machinery to induce DSBs.
Securin-depleted cells show GCR and decrease viability after Adr treatment in different backgrounds
To rule out the possibility that the results obtained were unique to HCT116 cells, U2OS human osteosarcoma cells were transfected with two independent, non-overlapping, 21 bp RNA duplexes with homology to human securin, and then either treated with Adr or left untreated as controls (Figure 4a and b). After incubation, a statistically significant proportion of cells with suppressed securin expression displayed an increase in the number of gross chromosomal abnormalities per cell versus U2OS control cells (mean±S.E.M.: 1.93±0.29, n=30 versus mean±S.E.M.: 0.8±0.24, n=30; P=0.0046, two-tailed unpaired t-test), confirming a role for securin in the maintenance of chromosomal stability after DNA damage (Figure 4c and d).
To avoid possible side effects of transient transfection of siRNAs, the securin gene was also inhibited in different backgrounds (HCT116, U2OS and HeLa cells) through expression of a short hairpin RNA (shRNA) complementary to securin, by lentivirus infection (Figure 5a). Western blot analysis showed the suppression of securin protein expression (Figure 5b). Importantly, shRNA-mediated silencing of securin reduces cell viability in the MTS assays in the three lines tested, HeLa, U2OS and HCT116 (Figure 5c–e). These results corroborate that low levels of securin, after Adr treatment, reduce the cell viability. To control for unexpected genetic alteration and to link cell sensitivity after DNA damage to the presence of securin, wild-type securin gene was reexpressed in sec−/− HCT116 cells by infecting with lentiviruses containing securin cDNA under the control of the CMV promoter. The infected cells rescued notably the Adr sensitivity observed in wild-type HCT116 cells (Figure 5e).
NHEJ is quantitatively normal in securin-deficient cells but occurs through aberrant end processing
The phenotypes observed by flow cytometry could be due to either a lack of repair halting the cells in the checkpoint or a downstream effect post-repair. We have previously shown that securin interacts with the Ku70-80 dimmer. This coupled to the fact that sec−/− HCT116 cells show a sensitivity profile to a particular DNA damage similar to known NHEJ proteins like Ku70 and Lig4 deficiency suggests a strong case for analysis of repair by NHEJ in these cells. This hypothesis was addressed by monitoring the DSB repair response using pulse field gel electrophoresis (PFGE) to detect the persistence of fragmented and thus unrepaired DNA over time. After irradiation with 5 Gy at different time points, only very large DNA fragments (>3.5 Mb) were observed and quantified (Figure 6b). Apoptotic DNA fragments are generally smaller than 50 kb and are clearly separated in PFGE, could not be observed at these time points. In both cell lines, time course experiments show that after 4 h post-IR the bulk of DSBs do not persist, signalling that all the DNA has been resealed. Furthermore, the NHEJ repair pathway was biochemically analysed using securin-deficient cells nuclear extracts. A linear plasmid bearing non-matching XhoI and PstI ends was used as standard NHEJ substrate (Figure 6a). Upon incubation in the sec−/− HCT116 nuclear extracts, this substrate underwent intramolecular NHEJ, giving rise to monomer covalently closed circles (CC). Scanning densitometry was used to quantify the bands on ethidium bromide-stained agarose gels and to determine the percentage of linear substrate that was rejoined. These experiments revealed that extracts from both cell lines efficiently rejoined the linear substrate, and no significant differences were detected, suggesting that end joining was proficient even in the absence of securin.
As the cell-extract assay is quantitative and does not detect alterations in the actual mechanism of repair, we searched for sequence changes at the site of damage as described previously.16 The assay uses two plasmids, uncleaved pCYCA184, which confers chloramphenicol resistance in transformed bacteria and it is used as a transfection control, and the plasmid pBluescript SK+ was introduced into cells as a linear fragment bearing non-matching XhoI and PstI ends to measure NHEJ. When recovered from eukaryotic transfected cells and reintroduced into bacteria, the recircularized plasmid pBluescript SK+ confers ampicillin resistance and serves as a quantitative measure of DNA end joining. Thus, after sec−/− HCT116 and sec+/+ HCT116 cells were transfected with the two plasmids, the recovered DNA was introduced into bacteria, and the colonies plated on ampicillin and chloramphenicol plates (Figure 7a). The number of colonies obtained for the two cell lines was similar on each of the antibiotic containing plates, indicating that DNA uptake, stability and amount of end joining were similar for securin-deficient and securin wild-type cells (data not shown).
Ku80-deficient cells show an increased extent of deletion at the ends of transfected DNA in this assay.16 To examine whether sec−/− HCT116 cells exhibited a similar phenotype, approximately 25 colonies were selected in each of three independent experiments, and recession length in the end-joined products was scored after sequencing the recovered plasmids (Figure 7b). In contrast to the wild type, plasmids recovered from sec−/− cells showed a surprisingly stark decrease in the amount of DNA deleted around the cut site, a measure of resection. Thus, while wild-type cells showed repair of substrate by NHEJ with the expected end processing (69.2% sec+/+ versus 16.6% in sec−/−, P<0.001, two-way ANOVA followed by Bonferroni post-test), a significant majority of plasmids in sec−/− cells were resealed with no end processing at all (11.5% in sec+/+ versus 53.3% in sec−/−, P<0.001, two-way ANOVA followed by Bonferroni post-test), demonstrating a role for securin in DSB repair through NHEJ. It should be noted that overexpression of securin over the endogenous level in sec+/+ HCT116 did not induce significant differences, neither in this end processing assays nor in the cell viability assays after DNA damage, compared to securin wild-type cells (Figure 5e and 7c). We also tested in these assays U2OS and HCT116 cells (Figure 7c and d) where securin was knocked down using shRNA. The results show that the abnormal end processing of DNA was not dependent on a particular cell line, but it is directly dependent on the presence of securin.
Discussion
Securin overexpression has been noted to be a common feature of several malignancies, often with a poor prognostic profile. Proliferative capacity after genotoxin exposure is a key trait in conferring chemoresistance and we demonstrate here that it is significantly reduced with loss of securin, suggesting possible driving forces behind the selection of increased protein levels in cancer. While the analysis of securin overexpression is often complicated by cell-cycle deregulation in vitro, our findings highlight the contribution of using genetic knockout systems to understanding the cause of its alterations in cancer.
We have previously described that the securin–Ku heterodimer interaction is affected by the induction of DSBs in DNA, suggesting a possible role for securin in the DNA damage response. Furthermore, in a recent publication McCabe and co-workers have described that overexpression of securin inhibits Ku–DNA heterodimer function and decreases the extent of repair.17 Here we add to the evidence that securin affects DNA repair after genotoxin exposure and show inaccurate repair in plasmid substrates in cells that are null for the protein.
Cells deficient in securin protein are viable with a normal cell-cycle profile under standard growth conditions.18 This is in agreement with the observation that securin knock-out mice are viable and fertile.19 However sec−/− cells are more sensitive to DSBs than are parental cells when exposed to IR, MMS or Adr, agents inducing lesions that are repaired by both HR and NHEJ, but not after exposure to CPT, which is repaired exclusively by HR.20
The spectrum of genotoxic sensitivity shown by securin-deficient cells is reminiscent of what has been described for Ku deficiency, that is to IR, MMS and Adr, but not to CPT.21, 22, 23, 24, 25 The CPT-mediated DNA damage has been shown to be unique among the agents used. This agent selectively traps topo I cleavage complexes by inhibiting the religation step, thereby inducing topo I-linked DSBs. Collisions of replication forks with topo I cleavage complexes generate ‘stalled fork’ DSBs, which are known to be preferentially repaired by HR as opposed to NHEJ.26, 27, 28, 29 Our results show no differences in sensitivity to CPT of sec−/− and wild-type cells, suggesting that HR is not affected by the absence of securin.
Even though securin-deficient cells were proficient for resealing DSBs induced in a reporter plasmid, subtle changes at the repair site on the substrate were observed. An intriguing possibility in light of this finding and previous work on the regulation of the Ku–securin interaction by DNA damage could be that securin functions to regulate Ku heterodimer binding to DNA at DSB sites. In the absence of securin, an increase in Ku binding at the DNA ends could explain the observation of decreased resection and promoted ligation. This model is further strengthened by published data showing a reverse phenotype compared to that in Ku-deficient cells, with more resection before ligation.16 The appearance of GCRs, not in proliferating cells but only after DNA damage, in cells lacking securin could thus be explained as a consequence of deregulated and therefore aberrant Ku-mediated ligation. Further biochemical work is required to elaborate on the precise mechanism of how securin affects end joining.
While securin-deficient cells have been proven to be unstable (loss or gain of complete chromosomes)18 this phenotype has been shown to relapse after 2 weeks in culture.14 It has also been noted that these cells grow normally in culture with no obvious aberrations in phenotypes such as doubling time, karyotype or cell-cycle profile, suggesting that they are a valid system for the study of DNA repair mechanisms. However, wild-type cells showed a different behaviour only after exposure to several DNA-damaging agents, as measured by a drop in number of colonies formed and appearance of GCRs. This loss in proliferative capacity after DNA damage in a securin deficiency background could be potentially used for targeting securin in synergy with known chemotherapeutic agents, particularly in tumours known to overexpress this protein.
Materials and Methods
Cell culture, treatments, clonogenic and viability assays
U2OS (human osteosarcoma) and HCT116 (human colorectal carcinoma) cells were purchased from ATCC. Dr. B Vogelstein kindly provided securin-deficient HCT116 cell line.18 Exponentially growing cells were treated with Adr and CPT at indicated concentrations for 6 h; for MMS treatments, cells were incubated for 1 h. Immediately after treatment, cells were trypsinized and replated in new flasks with fresh media. Cells were grown for 12 days and then stained with crystal violet and counted. For viability assays, cells were plated in 96-well plates at 8000 cells/well, treated as described above, and 3 days later the relative number of viable cells were determined using the CellTiter96 Aqueous assay kit (Promega). This assay is based on cellular conversion of the tetrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) to formazan product that is soluble in culture medium and quantified by absorbance at 490 nm. Absorbance is proportional to the number of viable cells.
Construction of securin siRNA in lentiviral vectors
The shRNA-specific for securin was synthesized as two complementary DNA oligonucleotides flanked with BglII and HindIII restriction sites. The sequences were 5′- GATCCCCGTCTGTAAAGACCAAGGGATTCAAGAGATCCCTTGGTCTTTACAGACTTTTTA-3′ and 5′-AGCTTAAAAAGTCTGTAAAGACCAAGGGATCTCTTGAATCCCTTGGTCTTTACAGACGGG-3′. The underlined sequence corresponds to the targeted sequence in securin. Oligonucleotides were annealed and ligated into pSuper vector (OligoEngine), and digested with BglII and HindIII. To create the shRNA lentivirus, the siRNA cassette, containing the H1 promoter and the hairpin siRNA sequence, was transferred from pSUPER to pSIN-DUAL-GFP by digestion of both vectors with XhoI and NotI, respectively, followed by a DNA polymerase I fill-in reaction, and a new digestion with EcoRI. The excised cassette was ligated into the pSIN-DUAL-GFP vector. For production of lentivirus, 106 293T cells were seeded onto a 10 cm Petri dish and transfected with 13.5 μg of transfer vector pSIN-DUAL-Securin, 9 μg of pCMVDR8.91 and 4.5 μg of pMDG plasmids using Lipofectamine 2000 (Invitrogen). Lentivirus were harvested 48 h after transfection, passed through a 0.45 μm filter, and concentrated by ultracentrifugation at 20 000 r.p.m. for 2.5 h. Virus particles were dissolved in serum-free DMEM-F12 (Invitrogen), snap-frozen in liquid nitrogen and stored at −80°C. For virus titration, 2 × 105 293T cells were infected with virus plus 8 μg/ml polybrene for 6 h. Infected cells were detected by EGFP expression using a FACScan and CellQuest software (BD Biosciences).
Flow cytometry and BrdU incorporation
HCT116 cell lines were treated with Adr at different concentrations. At the indicated times, floating and adherent cells were processed for flow cytometry analysis as described.30 DNA synthesis was assessed by BrdU incorporation for 12 h (Cell Proliferation Elisa, BrdU Colorimetric, Boehringer) in both HCT116 cell lines after 48 h of Adr incubation according to manufacturer's instructions.
siRNA-mediated securin silencing
Securin and control siRNAs consisting of 21 bp with a 2-base deoxynuneotide overhang were purchased from Proligo (France, SAS). Cells were seeded on 35 mm culture dishes and transfected with 50 nM siRNA using oligofectamine (Invitrogen) according to the manufacturer's instructions. Twenty-four hours post-transfection, RNA and protein were isolated from each dish and securin knockdown was validated by northern and western blot respectively. Cells stably expressing shRNA construct against securin mRNA were generated by lentiviral gene transfer. For infection with lentivirus stock, U2OS, HCT116 and HeLa cells were plated in 60 mm plates and incubated 2 h in their complete medium and then supplemented with lentiviral particles (MOI 0.4) and 8 μg/ml polybrene for 6 h at 37°C. Media were changed to growth media without polybrene for the rest of the experiment. Two days post-infection, cells were expanded as bulk populations.
Laser scanner confocal microscopy
Cells were grown on chamber slides, treated as indicated, and fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 10 min. After permeabilization in PBS+0.05% Triton X-100 for 10 min, cells were incubated in blocking solution (5% foetal bovine serum in PBS) for 10 min. Rabbit antibodies against human γ-H2AX were obtained from Upstate Biotechnologies and used at 1 : 200 dilution in blocking solution+0.05% Tween-20 for 1 h. Slides were then washed three times in PBS+0.05% Tween-20 and incubated with FICT-conjugated anti-rabbit secondary antibodies at 1 : 100 for 45 min. Slides were washed as above and mounted prior to fluorescence confocal microscopy.
Immunoblot analysis
Cells were lysed in NP40 buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 1% (v/v) NP40) containing a complete cocktail of protease inhibitors (Roche) and 1 mM PMSF. Proteins were resolved on SDS-PAGE gels for detection of securin and β-actin. Immunoblotting was performed using the rabbit polyclonal anti-human securin described previously,1 rabbit polyclonal anti-human PARP-1 (Roche), rabbit polyclonal anti-human caspase 3 (Cell Signaling) and monoclonal anti-human β-actin (Sigma).
Pulse field gel electrophoresis
DSB induction and repair assays have been described previously in detail.30 Briefly, cells were irradiated and incubated at 37°C at the indicated times. Agarose plugs containing 2 × 106 cells/ml were prepared and incubated at 50°C for 38 h in lysis solution containing L-laurylsarcosine and proteinase K (Sigma-Aldrich). DNA fragment migration was resolved using pulsed-field gel electrophoresis (CHEF DRII; Bio-Rad) with a 4-day migration programme discriminating the megabase-sized fragments. Under these conditions, only fragments of <3.5 Mb are able to migrate out of the well. DSB data were expressed as the fraction of DNA fragments migrating out of the well after quantifying the light that each migration lane emitted in the ethidium bromide-stained gel using a densitometer. Chromosomal Schizosaccharomyces pombe DNA size standards (Bio-Rad) were used in each experiment to evaluate DNA fragment size all along the migration lane.
End-joining reactions
In vitro NHEJ assay was carried out using nuclear extracts prepared from sec−/− HCT116 cells or control sec+/+ HCT116 cells, as described previously.31 Circular pBluescript SK+ plasmid DNA was linearized by restriction digestion with PstI and XhoI to generate non-cohesive ended substrates. After restriction digest, 1 μg of linearized DNA was incubated with 5 μg of nuclear protein extract in 70 mM Tris (pH 7.5), 10 mM MgCl2, 10 mM dithiothreitol and 1 mM ATP in a total volume of 50 μl for 12 h at 14°C. The reaction mixture was then treated with proteinase K at 37°C for 30 min and electrophoretically separated on a 0.8% agarose gel in Tris–borate–EDTA. Gels were scanned after staining with ethidium bromide.
Extrachromosomal DSB repair NHEJ assay
In vivo NHEJ assay with extrachromosomal DNA was carried out as described previously.16 The different cell lines were transfected with plasmids, 2 μg of pBluescript SK+ or pEGFP digested with PstI and XhoI and 20 ng of uncleaved pACYC184, using the jetPEI™ reagent (Qbiogene). DNA was recovered from cells and reintroduced into DH5α Escherichia coli bacteria. The recircularized pBluescript SK+ plasmid confers ampicillin resistance (AmpR) and pEGFP plasmid confers kanamycin resistance (KanR), which is used as DNA end-joining measurement. Uncleaved plasmid pACYC184 confers choramphenicol resistance (CmfR) to bacteria when recovered from the transfected cells and was introduced into mammalian cells as a transfection control.
Chromosomal analysis
To examine the effects of Adr treatment we used sec−/− HCT116, sec+/+ HCT116 or U2OS cells expressing siRNA against securin. Cells were exposed to 0.05 μg/ml for 2 h and allowed to recover at 37°C for 24 h in fresh media before chromosome preparation. After recovery, cells were harvested and treated with 0.075 M KCl for 8 min at 37°C, fixed in methanol/acetic acid (3/1), spread on a glass microscope slide, air dried and Giemsa stained for GTG banding, performed as described previously.32
Statistical analysis
Unpaired t-test with two-tailed P-value and two-way ANOVA with Bonferroni post-test were performed using GraphPad Prism version 5.00 for Windows, GraphPadSoftware, San Diego USA (www.graphpad.com).
Abbreviations
- Adr:
-
adriamycin
- BrdU:
-
bromodeoxyuridine
- CPT:
-
camptothecin
- DSB:
-
double-strand break
- GCR:
-
gross chromosomal rearrangement
- HR:
-
homologous recombination
- IR:
-
ionizing radiation
- MMS:
-
methyl methanesulphonate
- NHEJ:
-
non-homologous DNA end joining
References
Dominguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M et al. hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene 1998; 17: 2187–2193.
Zhang X, Horwitz GA, Prezant TR, Valentini A, Nakashima M, Bronstein MD et al. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol 1999; 13: 156–166.
Saez C, Japon MA, Ramos-Morales F, Romero F, Segura DI, Tortolero M et al. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 1999; 18: 5473–5476.
Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S . Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 2000; 355: 716–719.
Saez C, Martinez-Brocca MA, Castilla C, Soto A, Navarro E, Tortolero M et al. Prognostic significance of human pituitary tumor-transforming gene immunohistochemical expression in differentiated thyroid cancer. The J Clin Endocrinol Metab 2006; 91: 1404–1409.
Ramaswamy S, Ross KN, Lander ES, Golub TR . A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33: 49–54.
Bernal JA, Luna R, Espina A, Lazaro I, Ramos-Morales F, Romero F et al. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet 2002; 32: 306–311.
Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE et al. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000; 404: 510–514.
Ferguson DO, Sekiguchi JM, Chang S, Frank KM, Gao Y, DePinho RA et al. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci USA 2000; 97: 6630–6633.
Gu Y, Seidl KJ, Rathbun GA, Zhu C, Manis JP, van der Stoep N et al. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity 1997; 7: 653–665.
Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ et al. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 1998; 95: 891–902.
Romero F, Multon MC, Ramos-Morales F, Dominguez A, Bernal JA, Pintor-Toro JA et al. Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase. Nucleic Acids Res 2001; 29: 1300–1307.
Jallepalli PV, Waizenegger IC, Bunz F, Langer S, Speicher MR, Peters JM et al. Securin is required for chromosomal stability in human cells. Cell 2001; 105: 445–457.
Pfleghaar K, Heubes S, Cox J, Stemmann O, Speicher MR . Securin is not required for chromosomal stability in human cells. PLoS Biol 2005; 3: e416.
Phillips JW, Morgan WF . Illegitimate recombination induced by DNA double-strand breaks in a mammalian chromosome. Mol Cell Biol 1994; 14: 5794–5803.
Liang F, Jasin M . Ku80-deficient cells exhibit excess degradation of extrachromosomal DNA. J Biol Chem 1996; 271: 14405–14411.
Kim DS, Franklyn JA, Smith VE, Stratford AL, Pemberton HN, Warfield A et al. Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity. Carcinogenesis 2007; 28: 749–759.
Jallepalli PV, Waizenegger IC, Bunz F, Langer S, Speicher MR, Peters JM et al. Securin is required for chromosomal stability in human cells. Cell 2001; 105: 445–457.
Mei J, Huang X, Zhang P . Securin is not required for cellular viability, but is required for normal growth of mouse embryonic fibroblasts. Curr Biol 2001; 11: 1197–1201.
Arnaudeau C, Lundin C, Helleday T . DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J Mol Biol 2001; 307: 1235–1245.
Adachi N, So S, Koyama H . Loss of nonhomologous end joining confers camptothecin resistance in DT40 cells. Implications for the repair of topoisomerase I-mediated DNA damage. J Biol Chem 2004; 279: 37343–37348.
Ninomiya Y, Suzuki K, Ishii C, Inoue H . Highly efficient gene replacements in Neurospora strains deficient for nonhomologous end-joining. Proc Natl Acad Sci USA 2004; 101: 12248–12253.
Milne GT, Jin S, Shannon KB, Weaver DT . Mutations in two Ku homologs define a DNA end-joining repair pathway in Saccharomyces cerevisiae. Mol Cell Biol 1996; 16: 4189–4198.
Ayene IS, Ford LP, Koch CJ . Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation. Mol Cancer Ther 2005; 4: 529–536.
Gallego ME, Bleuyard JY, Daoudal-Cotterell S, Jallut N, White CI . Ku80 plays a role in non-homologous recombination but is not required for T-DNA integration in Arabidopsis. Plant J 2003; 35: 557–565.
Pourquier P, Pommier Y . Topoisomerase I-mediated DNA damage. Adv Cancer Res 2001; 80: 189–216.
Furuta T, Takemura H, Liao ZY, Aune GJ, Redon C, Sedelnikova OA et al. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J Biol Chem 2003; 278: 20303–20312.
Vance JR, Wilson TE . Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage. Proc Natl Acad Sci USA 2002; 99: 13669–13674.
Nitiss J, Wang JC . DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc Natl Acad Sci USA 1988; 85: 7501–7505.
Foray N, Priestley A, Alsbeih G, Badie C, Capulas EP, Arlett CF et al. Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int J Radiat Biol 1997; 72: 271–283.
Lundberg R, Mavinakere M, Campbell C . Deficient DNA end joining activity in extracts from fanconi anemia fibroblasts. J Biol Chem 2001; 276: 9543–9549.
Thalhammer S, Koehler U, Stark RW, Heckl WM . GTG banding pattern on human metaphase chromosomes revealed by high resolution atomic-force microscopy. J Microsc 2001; 202 (Part 3): 464–467.
Acknowledgements
We are grateful to AD Jeyasekharan for helping in the English edition of the manuscript, and to B Vogelstein for HCT116 sec−/− cells, to J Sánchez for advice on chromosomal analysis and M Shivji for critical reading of the manuscript. JAP-T and MT were supported by grants from the Spanish Ministerio de Ciencia y Tecnología and the DGUI of the Junta de Andalucía. CM-V is a recipient of a postdoctoral contract (Program Juan de la Cierva) from the Spanish Ministerio de Educación y Ciencia.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by M Oren
Supplementary Information accompanies the paper on Cell Death and Differentiation website (http://www.nature.com/cdd)
Supplementary information
Rights and permissions
About this article
Cite this article
Bernal, J., Roche, M., Méndez-Vidal, C. et al. Proliferative potential after DNA damage and non-homologous end joining are affected by loss of securin. Cell Death Differ 15, 202–212 (2008). https://doi.org/10.1038/sj.cdd.4402254
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4402254
Keywords
This article is cited by
-
EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressiveness
British Journal of Cancer (2019)
-
Does securin expression have significance in prognostication of oral tongue cancer? A pilot study
European Archives of Oto-Rhino-Laryngology (2016)
-
Pathogenesis of pituitary tumors
Nature Reviews Endocrinology (2011)
-
Pituitary tumor transforming gene 1 regulates Aurora kinase A activity
Oncogene (2008)